Knight Therapeutics Inc. ( KHTRF) - Key Metrics
KHTRF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.47 | -$0.03 | $0.30 | $0.29 |
| 2026Q1 | $1.51 | $0.13 | $0.41 | $0.38 |
| 2025Q4 | $1.34 | $0.09 | $0.35 | $0.34 |
| 2025Q3 | $1.22 | -$0.04 | $0.11 | $0.10 |
| 2025Q2 | $1.08 | -$0.13 | $0.20 | -$0.05 |
KHTRF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -71.60 |
| 2026Q1 | 0% | 14.24 |
| 2025Q4 | 0% | 16.73 |
| 2025Q3 | 0% | -40.37 |
| 2025Q2 | 0% | -11.04 |
KHTRF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.00% | 0% |
| 2026Q1 | 5.11% | 0% |
| 2025Q4 | 5.70% | 0% |
| 2025Q3 | 1.66% | 0% |
| 2025Q2 | -0.85% | 0% |
KHTRF
Price: $7.71
52 week price:
Earnings Per Share: 0.11 USD
P/E Ratio: 62.25
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 731.8 million